Dr. Ho graduated from the St Matthew's Univ Grand Cayman in 2003. He works in Philadelphia, PA and 1 other location and specializes in Family Medicine and Internal Medicine. Dr. Ho is affiliated with Delaware County Memorial Hospital.
Benign Prostatic Hypertrophy Bladder Cancer Calculus of the Urinary System Erectile Dysfunction (ED) Kidney Cancer
Languages:
Chinese English Spanish
Description:
Dr. Ho graduated from the University of Texas Medical School at San Antonio in 1989. He works in Houston, TX and specializes in Urology. Dr. Ho is affiliated with Baylor St Lukes Medical Center, Houston Methodist Hospital, Memorial Hermann Texas Medical Center and Texas Childrens Hospital.
Dr. Ho graduated from the Taipei Med Coll, Taipei, Taiwan (385 04 Prior 1/71) in 1980. He works in Alexandria, VA and specializes in Internal Medicine.
Medical School Indiana University School of Medicine Graduated: 1992
Languages:
English
Description:
Dr. Ho graduated from the Indiana University School of Medicine in 1992. He works in Redding, CA and specializes in Anesthesiology. Dr. Ho is affiliated with Mercy Medical Center Redding.
Moriya Tsuji - New York NY, US David D. Ho - New York NY, US Doug Wu - San Diego CA, US Masakazu Fujio - San Diego CA, US
Assignee:
The Rockefeller University - New York NY The Scripps Research Insititute - La Jolla CA
International Classification:
A61K 39/00 C07H 17/02
US Classification:
4241841, 536 179
Abstract:
This invention relates to immunogenic compounds which may serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
Glycolipids And Analogues Thereof As Antigens For Nkt Cells
Moriya Tsuji - New York NY, US David D. Ho - New York NY, US Douglass Wu - San Diego CA, US Masakazu Fujio - San Diego CA, US Xiangming Li - Elmhurst NY, US
Assignee:
The Rockefeller University - New York NY The Scripps Research Institute - La Jolla CA
International Classification:
A61K 39/00 C07H 17/02
US Classification:
4241841, 536 179
Abstract:
This invention relates to immunogenic compounds which serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
This disclosure is directed, inter alia, to polynucleotides, polypeptides, vectors, cells and compositions comprising the same, and their use in affecting viral pathogenesis, in particular for influenza viral infection.
Glycolipids And Analogues Thereof As Antigens For Nkt Cells
Moriya Tsuji - New York NY, US David D. Ho - New York NY, US Douglass Wu - San Diego CA, US Masakazu Fujio - San Diego CA, US Xiangming Li - Elmhurst NY, US
Assignee:
The Rockefeller University - New York NY The Scripps Research Institute - La Jolla CA
International Classification:
A61K 39/00
US Classification:
4241841, 536 179
Abstract:
This invention relates to immunogenic compounds which serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
Glycolipids And Analogues Thereof As Antigens For Nkt Cells
Moriya Tsuji - New York NY, US David D. Ho - New York NY, US Douglass Wu - San Diego CA, US Masakazu Fujio - San Diego CA, US Xiangming Li - Elmhurst NY, US
Assignee:
The Rockefeller University - New York NY The Scripps Research Institute - La Jolla CA
International Classification:
A61K 39/00
US Classification:
4241841, 536 179
Abstract:
This invention relates to immunogenic compounds which serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
David Ho - New York NY, US Yaoxing Huang - New York NY, US Craig Pace - New York NY, US Ruijiang Song - New York NY, US Qing Fang - New York NY, US
Assignee:
The Rockefeller University - New York NY
International Classification:
A61K 39/00 A61K 39/42 A61K 39/395 A61K 38/00
US Classification:
4241361, 4241601, 4241721, 514 11
Abstract:
Disclosed herein are fusion antibodies created to provide both an antigen-binding site that targets the CD4 receptor and an antigen-binding site that targets the HIV envelope. The fusion antibodies disclosed herein provide improved potency and breadth against HIV as compared to monospecific antibodies, and additionally provide high barrier against viral resistance. Also disclosed are pharmaceutical formulations and therapeutic methods utilizing such fusion proteins.
Vaccination Of Hiv Infected Persons Following Highly Active Antiretrovial Therapy
The present invention provides a method of permitting cessation of antiviral therapy on HIV-infected subjects without virus rebound or with at least a delayed virus rebound or a decreased post rebound set-point. The method comprises the re-induction of HIV-specific immune responses using a vaccination strategy to induce both humoral and cell-mediated immunity. The present invention achieves an immunological control of persistent infectious virus after discontinuation of antiviral therapy. The vaccine strategy according to the invention is both safe and immunogenic in the subject HIV-infected patient population.
Linqi Zhang - Rochelle Park NJ, US David Ho - Chappaqua NY, US Rebecca Caffrey - Redwood City CA, US Enrique Dalmasso - Fremont CA, US Jianfeng Mei - Guilford CT, US
International Classification:
A61K039/00 A61K038/17
US Classification:
424/185100, 514/012000
Abstract:
The present invention relates to inhibition of viruses, e.g., HIV, using defensins. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions, antibodies, peptides, nucleic acids, antisense nucleic acids, and ribozymes, that increase naturally occurring defensin expression or activity, thereby inhibiting HIV in a cell; as well as to the use of expression profiles and compositions in diagnosis and prophylaxis, and therapy related to HIV infection and related disease states such as AIDS.
Jan 2010 to 2000 Associate Vice Dean Finance/CFOThe University of Chicago Medical Center
Dec 2006 to Jan 2010 Vice President for FinanceThe University of Chicago Medical Center
Aug 2006 to Dec 2006 Executive Director, Budget & Financial OperationsThe University of Chicago Medical Center
2005 to 2006 Executive Director, FinanceThe University of Chicago Medical Center
2004 to 2005 Executive Director, Budget Operations & Resource AnalysisThe University of Chicago Medical Center
1998 to 2004 Director of Budget OperationsNew York University Medical Center
1988 to 1998 Director - Budget & PlanningNew York University Medical Center
1986 to 1988 Associate Director - Budget & PlanningNew York University Medical Center
1984 to 1986 Assistant Budget DirectorNew York City Office of Management & Budget (OMB)
1983 to 1984 Senior Revenue AnalystOMB
1981 to 1983 Revenue AnalystCabrini Medical Center New York, NY 1979 to 1980 Administrative Resident
Education:
University of Chicago Graduate School of Business Jun 2004 certificate in business managementBaruch College - Mount Sinai School of Medicine City University of New York Jan 1978 to Jan 1980 MBA in Health Care ManagementCornell University 1974 to 1978 BA in Economics
Jun 2012 to Present DirectorMarketing & Communications New York, NY Dec 2011 to May 2012 ManagerWiredset LLC New York, NY Sep 2011 to Nov 2011 Marketing InternCanal 9 Buenos Aires, Buenos Aires Jun 2009 to Jan 2011 Audience AnalystNascent Art New York, NY 2008 to 2009 Art Consultant
Education:
University of Southern California Los Angeles Los Angeles, CA May 2008 Bachelor of Arts in Advertising, Art History
Skills:
Social TV, Television, Digital Media, Marketing
Name / Title
Company / Classification
Phones & Addresses
David Ho President
Apex Travel Ltd Travel Agencies
946 W 7th Ave, Vancouver, BC V5Z 1C3 6047399772, 6047399782
David Ho President
Mastertour Travel Travel Agencies
200 841 W Broadway, Vancouver, BC V5Z 1J9 6042664015, 6042662633
David Ho President
Apex Travel Ltd Travel Agencies
6047399772, 6047399782
David Ho Owner
China Aids Initiative Ret Misc Homefurnishings
455 1 Ave, New York, NY 10016
David Ho President
Mastertour Travel Travel Agencies
6042664015, 6042662633
David Ho CEO
Arron Diamond Aids Research Research Service
455 1 Ave, New York, NY 10016 2127252323, 2127251126
Suntec Tower 4, SingaporeDirector, South Asia - Consulting at Oracle Past: Regional Director, ASEAN at Epicor Software Corporation, Director, Business Development at... Oracle Consulting focuses exclusively on the success of companies deploying Oracle Applications and technology. Our experts deliver on Oracle’s commitment: to... Oracle Consulting focuses exclusively on the success of companies deploying Oracle Applications and technology. Our experts deliver on Oracle’s commitment: to ensure that you benefit from a trusted lifetime partnership with Oracle and to help you achieve your business goals.
Oracle Consulting...
Wharton School of the University of Pennsylvania, University of Chicago Law School
Tagline:
Exodus 21:5
David Ho
About:
123木é 人
David Ho
Education:
University of Detroit Mercy - Doctor of Dental Surgery, University of Toledo - Pediatric Dentistry
David Ho
Education:
Michigan State University - English, Chicago–Kent College of Law - Law
David Ho
Education:
University of North Carolina at Charlotte - Marketing
About:
I'm Chinese and soon to be graduate at UNC Charlotte in Marketing. I like to have fun and live care free. I'm currently talking to someone special at the moment but accepting friends. :) Â Hi...